Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Goes far beyond the readOnly/idempotent annotations by disclosing internal cascade behavior, graceful degradation ('if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return'), ambiguity handling ('asserts nothing and returns figi_candidates'), and explicit `unresolved` listing. It also clarifies source labeling and ISIN-to-LEI mapping. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with sample queries and has clear SUPPORTED TYPES sections, but the `company` entry contains a very long nested parenthetical that is dense and run-on, making it harder to parse. Most sentences earn their place, but the structure could be tightened with bullet lists to improve scannability.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the burden of explaining return artifacts: it covers `figi_candidates`, `unresolved`, source-labeled identifiers, RxCUI plus ingredient/brand/citation, and degradation behavior. For a multi-source resolver with two entity types, nothing critical is missing for an agent to invoke it correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, yet the description adds significant value: it explains the `value` param with examples (AAPL, 0000320193, ozempic), a detailed caveat about bond issuer naming, and ISIN input behavior. The `type` enum is expanded into meaningful subtypes. This exceeds the baseline 3 for full schema coverage.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a precise verb+resource: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It names concrete supported types (company, drug) and explicitly frames itself as the first step when a name is present but an ID is needed. This distinguishes it from ID-consuming sibling tools even though none are named directly.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides explicit when-to-use guidance: 'Use FIRST whenever you have a name but need an ID.' It also gives concrete value-passing instructions with pitfalls ('for a bond that is the ISSUER exactly as printed... never the question's full noun phrase'). It does not explicitly name alternative tools or state when NOT to use it, but the precedence rule and examples give strong contextual direction.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.2/5.0
Disambiguation3/5

Tools like ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded have overlapping purposes (all answer questions via a universal router), with only subtle distinctions (beta version, grounded mode). Additionally, many tools like entity_profile, compare_entities, recent_changes, and resolve_entity all pull SEC/company data, and polymarket_arbitrage, polymarket_edges, polymarket_fill_risk, bet_research all relate to prediction markets, creating potential confusion. However, each tool does have a somewhat distinct purpose and detailed descriptions help differentiate them, so it's not extreme overlap.

Naming Consistency2/5

Tool names are mostly lowercase with underscores (e.g., 'ask_pipeworx', 'compare_entities', 'resolve_entity'), but there's a mix of verb-first (bulk_splits, list_subscriptions) and noun-first (data_types, get_quote) patterns. Also 'aggregates' and 'grouped_daily' both fetch bars but have different naming styles. The naming is inconsistent with no clear uniform pattern, and some names are vague like 'helpers' or 'utility-*'.

Tool Count2/5

43 tools is quite heavy for a single MCP server, exceeding the typical 15-25 range for 'too many'. While the server aggregates many different domains (Polygon stocks, Pipeworx data, Polymarket, npm, etc.), the sheer number makes it overwhelming for an agent to discover and select the right tool. Many tools are meta-tools (ask_pipeworx, discover_tools) that add complexity rather than mapping to a clear domain.

Completeness4/5

The server covers a huge range of operations: stock data (retrieve, search, details), prediction markets (arbitrage, edges, research, fill risk), entity resolution, subscriptions, memory, and meta-tools. There are some gaps like no obvious tool for modifying stock data (not expected) and the Polymarket side lacks a tool for placing actual trades or managing positions. But overall the surface is quite complete for a comprehensive data/research server.